Response by Bohula et al to Letters Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)"

Circulation. 2018 Jun 12;137(24):2662-2663. doi: 10.1161/CIRCULATIONAHA.118.034500.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acute Coronary Syndrome*
  • Anticholesteremic Agents*
  • Ezetimibe
  • Ezetimibe, Simvastatin Drug Combination
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*
  • Stroke*

Substances

  • Anticholesteremic Agents
  • Ezetimibe, Simvastatin Drug Combination
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Ezetimibe